Stock Information
Amgen Inc (AMGN)
Ticker Symbol: AMGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $185,021.97 mil
Piotroski score: 8
PE Ratio: 26.7772
EPS (TTM): 12.9374
Revenue (TTM): $66.37 M
Dividend Yield: 2.9238577%
ROE: 96.19%
Latest News
-
Viridian Therapeutics: Cautious Optimism As Key Milestones Approach (Rating Downgrade)
Mon, Jan 26, 2026 2:05 PM
-
Amgen's (NASDAQ:AMGN) 11% CAGR outpaced the company's earnings growth over the same five-year period
Mon, Jan 26, 2026 12:00 PM
-
Q3 Rundown: Amgen (NASDAQ:AMGN) Vs Other Therapeutics Stocks
Mon, Jan 26, 2026 3:31 AM
-
Dow Jones Stocks: Nvidia, Amgen Are Near Buy Points But This Longtime Loser Is Winning The Week
Fri, Jan 23, 2026 6:49 PM
-
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Fri, Jan 23, 2026 2:00 PM
-
CFOs On the Move: Week ending Jan. 23
Fri, Jan 23, 2026 9:34 AM
-
Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy?
Thu, Jan 22, 2026 11:11 PM
-
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
Thu, Jan 22, 2026 11:00 PM
-
Procter & Gamble, 3M share gains lead Dow's nearly 450-point jump
Thu, Jan 22, 2026 11:45 AM
-
Amgen: A Buy In 2026 On Exciting MariTide Obesity - T2D Potential
Thu, Jan 22, 2026 11:15 AM
Key Financials
Financial data not available